Detalhe da pesquisa
1.
Protein Based Amorphous Solid Dispersion: a Case Study Investigating Different Whey Proteins at High Drug Loading.
Pharm Res
; 40(7): 1865-1872, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237165
2.
Inhibition of S.â aureus Infection of Human Umbilical Vein Endothelial Cells (HUVECs) by Trehalose- and Glucose-Functionalized Gold Nanoparticles.
Angew Chem Int Ed Engl
; 60(42): 22652-22658, 2021 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387412
3.
The application of crystallization in the presence of additives to enable drug-in-capsule technology.
Pharm Dev Technol
; 22(6): 804-808, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27279563
4.
Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design.
Adv Drug Deliv Rev
; 209: 115322, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677443
5.
Drug delivery breakthrough technologies - A perspective on clinical and societal impact.
J Control Release
; 360: 335-343, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364797
6.
Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model.
Invest New Drugs
; 30(3): 936-49, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21360050
7.
pH-Induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties.
Pharm Res
; 29(10): 2738-53, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22580905
8.
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities.
Expert Opin Drug Deliv
; 19(10): 1265-1283, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877189
9.
Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development.
Pharmaceutics
; 13(10)2021 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34683975
10.
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.
BMC Psychiatry
; 10: 45, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20537130
11.
Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics.
J Control Release
; 321: 475-482, 2020 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32105759
12.
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge.
Adv Drug Deliv Rev
; 167: 66-77, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473188
13.
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules.
AAPS J
; 22(2): 21, 2020 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900602
14.
Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development Interface.
J Pharm Sci
; 108(1): 87-101, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30385285
15.
The Glycogen Synthase Kinase-3ß Inhibitor LSN 2105786 Promotes Zebrafish Fin Regeneration.
Biomedicines
; 7(2)2019 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010223
16.
Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs.
Int J Pharm
; 526(1-2): 443-454, 2017 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473237
17.
Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture.
Tuberculosis (Edinb)
; 98: 92-6, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156623
18.
Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth.
Mol Cancer Ther
; 15(10): 2344-2356, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27439478
19.
Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalence.
AAPS J
; 14(3): 627-38, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22684402
20.
Overview of challenges and opportunities in drug delivery and pharmaceutics.
Ther Deliv
; 6(8): 911-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305510